Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06413888 · ClinicalTrials.gov registry record · NA
Nasogastric Decompression Following Pancreaticoduodenectomy
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT06413888 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 230 participants.
The verdict
NCT06413888, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recently, the implementation of ERAS protocol recommended against routine use of nasogastric tube following PD. however, limited data exists surrounding the identification of those patients needing NGT decompression in the immediate postoperative period. Therefore, we initiated a large prospective randomized controlled trial to evaluate the clinical outcomes of patients who retained the NGT post-PD versus those who had it removed at the end of the procedure. This study aims to assess the effectiveness of nasogastric decompression in PD recovery, with the primary endo point being the need for and impact of NGT in the postoperative recovery. The secondary endpoint will examined the re-insertion rate of NGT and identify factors that necessitate its use in the immediate postoperative period.
Interventions
- PROCEDURE pancreaticoduodenectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06413888
The ClinicalTrials.gov registry entry for NCT06413888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pancreaticoduodenectomy is the first listed.
NCT06413888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06413888 about?
NCT06413888 is a clinical study titled "Nasogastric Decompression Following Pancreaticoduodenectomy". Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recent...
What is the current status of trial NCT06413888?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2018-06-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT06413888?
The interventions under investigation include: pancreaticoduodenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06413888?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.